ReleaseWire Connect

Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. This disease affects over 170 million females across the globe. Endometriosis has an unclear etiology and complex symptoms. These factors contribute in difficulties for timely diagnosis and obstruct the drug discovery processes. Endometriosis is a major cause of infertility in female population. Endometriosis treatment includes pain management through hormonal therapies and surgical interventions. The global endometriosis pharmaceuticals market comprises majorly of four drug types, namely Gonadotrophin Releasing Hormone agonists (GRH), Non-Steroidal Anti-Inflammatory drugs (NSAIDs), progestins, and contraceptive pills.

The National Institute of Mental Health in the US states that every 1 in 4 adults suffers from a brain disorder every year. It further asserts that at least 6% suffer from serious disabilities due to severe brain damage. This alarming statistic goes to show the dire need for brain monitoring devices in the global healthcare industry today. Research shows that brain monitoring devices will be in significant demand in critical care units due to a high incidence of accidents pertaining to brain trauma and injuries in recent past. The market offers a wide range of devices to treat the abnormal brain activities and restore its functioning, depending on the case.

Over the past few decades, the development and design of microfluidic devices and components has been an exciting area in the pharmaceutical and life sciences industries. The developments are further driven by a variety of emerging analytical applications in various end-use industries. Microfluidics has been the key technology to engineer microminiaturized medical devices. Among the various use of the technology, microfluidic components have gained popularity in making lab-on-a-chip system. Owing to crucial advantages, including rapid test results and low cost, and marked simplicity, the system is growing in prominence for making robust chemical and biological analyses. Advances made in the point-of-care testing is further expected to expand the applications of microfluidic device system.

In a latest research report published by Transparency Market Research (TMR) "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", the global biomaterials market is forecasted to grow at a CAGR of 4.1% between 2013 and 2019. According to the report, the market is estimated to be valued at US$33,600 million by 2019, increasing from US$25,277.8 million in 2012.Biomaterials are fabricated from either synthetic or natural origin materials that are used for medical implants. Heart valves, dental implants, artificial hip joints, and intraocular lenses are some of the commonly used medical implants for which biocompabitility and safety needs to be guaranteed, since these implants come in close proximity to internal organs in the human body. Owing to such reasons it necessary that biomaterials are biocompatible, which means they should not interfere with the physiology and not cause any immunogenic reaction in the human body.

Spectrometry is a scientific technique employed to access properties of light within specific electromagnetic spectrum to identify variety of materials. In the past few decades spectrometry techniques have been resilient enough in providing scientists an informative tool to cater to vast array of applications in various industries. Overall competition in spectrometry market is intense with large conglomerates competing for considerably small application areas and end user segments.

This 72-page research publication, titled "Facial Injectables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", states that developing at a steady CAGR of 14.60% from 2014 to 2020, the global facial injectables market is projected to grow from a value of US$3.3 bn in 2013 to US$9.4 bn by 2020.

In 2013, the global orthodontic equipment and consumables market was worth US$6.1 bn and by 2020, the market is projected to be worth US$11.0 bn. The global orthodontic equipment and consumables market is driven by the rising popularity of cosmetic dentistry, technological advancements in orthodontic treatment technologies, rising prevalence of malocclusion, and the expanding dental tourism market.

The rising demand for minimally invasive surgeries, together with the increasing awareness pertaining to the benefits offered by surgical navigation systems, is driving the worldwide surgical navigation systems market to a great extent. However, the high cost associated with equipment is projected to limit the sales of surgical navigation systems in the global arena, states the market report.According to the research study, the global surgical navigation systems market has been classified on the basis of product type. ENT navigation systems, orthopedic navigation systems, and neurosurgical navigation systems are the major products available in the surgical navigation systems market.

The research report states that the global telemedicine market was valued at US$14.3 bn in 2014 and is estimated to reach US$36.3 bn by 2020, growing at a CAGR of 14.30% from 2014 to 2020.The global telemedicine market has been witnessing a boom due to the growing demand for privacy, increasing government expenditure, supportive reimbursement policies, and rise in the demand for personal healthcare. In addition to this, the efforts of global telemedicine market players to tap into the unmet medical needs in remote places and the increasing patient pool in rural areas will also help the proliferation of this market.

Methicillin-resistant staphylococcus aureus (MRSA) infections are caused due to Staphylococcus aureus bacterium which infects different parts of the body. These infections are difficult to treat due to high degree of resistance of these pathogens to the most commonly used antibiotics such as methicillin, amoxicillin, penicillin and oxacillin. The bacterium infects different parts of the body namely, skin, surgical wounds, blood streams, lungs, IV or other sites where the tubes such as catheters enter the body or the urinary tract and cause infection which can be life threatening.